Hörl WH - Search Results

1

Nonsteroidal Anti-Inflammatory Drugs and the Kidney.

Hörl WH. Hörl WH. Pharmaceuticals (Basel). 2010 Jul 21;3(7):2291-2321. doi: 10.3390/ph3072291. Pharmaceuticals (Basel). 2010. PMID: 27713354 Free PMC article. Review.

2

The versatility of HDL: a crucial anti-inflammatory regulator.

Säemann MD, Poglitsch M, Kopecky C, Haidinger M, Hörl WH, Weichhart T. Säemann MD, et al. Among authors: horl wh. Eur J Clin Invest. 2010 Dec;40(12):1131-43. doi: 10.1111/j.1365-2362.2010.02361.x. Eur J Clin Invest. 2010. PMID: 20695882 Review.

3

Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy.

Hörl WH. Hörl WH. J Investig Med. 2005 Nov;53(7):366-70. doi: 10.2310/6650.2005.53709. J Investig Med. 2005. PMID: 16297364 Review.

4

Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells.

Weichhart T, Haidinger M, Katholnig K, Kopecky C, Poglitsch M, Lassnig C, Rosner M, Zlabinger GJ, Hengstschläger M, Müller M, Hörl WH, Säemann MD. Weichhart T, et al. Among authors: horl wh. Blood. 2011 Apr 21;117(16):4273-83. doi: 10.1182/blood-2010-09-310888. Epub 2011 Mar 2. Blood. 2011. PMID: 21368289 Free article.

5

Gender and living donor kidney transplantation.

Khalifeh N, Hörl WH. Khalifeh N, et al. Among authors: horl wh. Wien Med Wochenschr. 2011 Mar;161(5-6):124-7. doi: 10.1007/s10354-011-0895-5. Wien Med Wochenschr. 2011. PMID: 21461802

6

A transient improvement in renal function occurs after ischemic stroke.

Haider DG, Ferrari J, Mittermayer F, Wolzt M, Hörl WH, Lalouschek W, Lang W. Haider DG, et al. Among authors: horl wh. Ren Fail. 2012;34(1):7-12. doi: 10.3109/0886022X.2011.623439. Epub 2011 Oct 25. Ren Fail. 2012. PMID: 22023107

7

Increased total cytokeratin-18 serum and urine levels in chronic kidney disease.

Roth GA, Lebherz-Eichinger D, Ankersmit HJ, Hacker S, Hetz H, Vukovich T, Perne A, Reiter T, Farr A, Hörl WH, Haas M, Krenn CG. Roth GA, et al. Among authors: horl wh. Clin Chim Acta. 2011 Apr 11;412(9-10):713-7. doi: 10.1016/j.cca.2010.12.030. Epub 2010 Dec 31. Clin Chim Acta. 2011. PMID: 21195700

8

Natriuretic peptides in chronic kidney disease and during renal replacement therapy: an update.

Khalifeh N, Haider D, Hörl WH. Khalifeh N, et al. Among authors: horl wh. J Investig Med. 2009 Jan;57(1):33-9. doi: 10.2310/JIM.0b013e318194f44b. J Investig Med. 2009. PMID: 19158605 Review.

9

N-terminal fragments of the proatrial natriuretic peptide in plasma and urine of kidney graft recipients.

Franz M, Woloszczuk W, Hörl WH. Franz M, et al. Among authors: horl wh. Transplantation. 2001 Jul 15;72(1):89-94. doi: 10.1097/00007890-200107150-00018. Transplantation. 2001. PMID: 11468540

10

Anaemia as a risk factor for the progression of chronic kidney disease.

Deicher R, Hörl WH. Deicher R, et al. Among authors: horl wh. Curr Opin Nephrol Hypertens. 2003 Mar;12(2):139-43. doi: 10.1097/00041552-200303000-00003. Curr Opin Nephrol Hypertens. 2003. PMID: 12589173 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

592 results

Search Page